These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2785955)

  • 1. T lymphocytes in infectious mononucleosis; effect of IL-2 on the outgrowth of Epstein-Barr virus-infected cells.
    Misko IS; Burrows SR; Schmidt C; Bishop CJ; Ryan JM; Staples JA; Moss DJ
    Immunol Cell Biol; 1989 Feb; 67 ( Pt 1)():49-55. PubMed ID: 2785955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
    Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E
    Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis.
    Robinson J; Smith D; Niederman J
    Nature; 1980 Sep; 287(5780):334-5. PubMed ID: 6252472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients.
    Rickinson AB; Crawford D; Epstein MA
    Clin Exp Immunol; 1977 Apr; 28(1):72-9. PubMed ID: 193663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line.
    Rickinson AB; Moss DJ; Allen DJ; Wallace LE; Rowe M; Epstein MA
    Int J Cancer; 1981 May; 27(5):593-601. PubMed ID: 6169663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
    Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA
    J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tinidazole on primary EBV infection and immunocompetence.
    Marklund G; Ernberg I; Britton S; Lundberg C
    Scand J Infect Dis; 1984; 16(1):17-23. PubMed ID: 6320359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E; Masucci MG
    Springer Semin Immunopathol; 1982; 5(1):63-73. PubMed ID: 6314570
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients.
    Rickinson AB; Moss DJ; Pope JH; Ahlberg N
    Int J Cancer; 1980 Jan; 25(1):59-65. PubMed ID: 6249763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1.
    McClain MT; Rapp EC; Harley JB; James JA
    J Med Virol; 2003 Jun; 70(2):253-7. PubMed ID: 12696112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.
    Svedmyr E; Jondal M
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1622-6. PubMed ID: 165518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic T cell reactivity to Epstein-Barr virus is lost during in vitro T cell expansion.
    Carlens S; Liu D; Ringdén O; Aschan J; Christensson B; Levitsky V; Dilber MS
    J Hematother Stem Cell Res; 2002 Aug; 11(4):669-74. PubMed ID: 12201955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G; Straus S; Henle W; Pike SE; Blaese RM
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis.
    Svedmyr E; Ernberg I; Seeley J; Weiland O; Masucci G; Tsukuda K; Szigeti R; Masucci MG; Blomogren H; Berthold W
    Clin Immunol Immunopathol; 1984 Mar; 30(3):437-50. PubMed ID: 6199144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ; McAulay KA; Anthony IC; Crawford DH
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants.
    Burrows SR; Misko IS; Sculley TB; Schmidt C; Gang D; Moss DJ
    Cell Immunol; 1990 Apr; 127(1):47-55. PubMed ID: 1690609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.